Jacques Theurillat has been appointed to the board of directors of 21 Invest Partners SA in Spain. Theurillat is the chief financial officer and a board member of Seronon International, a leading global biotech company. He is also managing director of Istituto Farmacologico Serono, the group’s holding company, and a member of the board of Abacus Conseil et Expertise Comptable SA. Theurillat’s appointment should prove a valuable reinforcement of the advisory capacity available to 21 Invest in Spain, and in particular to the 21 Invest Industry fund, the recently established fund for industrial investments in Southern Europe.
The fund has around EURO300 million in commitments, with a final closing extended to the end of March.